AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study Post author:Sam Post published:December 3, 2017 Post category:BioPharma Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace You Might Also Like Why This Pharma Surged After Trump's Opioid Declaration October 26, 2017 Former PTC Therapeutics Exec Jumps Ship to Orchard Therapeutics as CEO August 9, 2017 Innate Pharma Regroups From Trial Failure With €410 Million Deal For Novo Nordisk A/S's AntiC5aR Antibody June 4, 2017
Innate Pharma Regroups From Trial Failure With €410 Million Deal For Novo Nordisk A/S's AntiC5aR Antibody June 4, 2017
